SCHEMBL8260987

SCHEMBL8260987

Cc1ccc(C(N)=O)c(N2CC3CCCCC(C2)C3C)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.41
GFER P55789 2/20 0.39
CDC7 O00311 1/20 0.38
CDK9 P50750 1/20 0.38
HCRTR1 O43613 4/20 0.37
HCRTR2 O43614 4/20 0.37
EPHX2 P34913 1/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SLC18A3 Q16572 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MAPT P10636 3/20 0.35
CCR1 P32246 1/20 0.34
CCR2 P41597 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
THRB P10828 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8259138 0.86 GAA (0.40) GAAGFERCDC7CDK9HCRTR1
SCHEMBL8259193 0.83 MGLL (0.39) GAAGFERALDH1A1HPGDMAPT
SCHEMBL8260270 0.76 GAA (0.38) GAAGFERALDH1A1HPGDSMN1; SMN2
SCHEMBL2563082 0.74 ALDH1A1 (0.51) GAACDC7CDK9NPC1RAB9A
SCHEMBL2559890 0.74 NOTUM (0.56) GAAHPGDKDM4EHSD17B10
SCHEMBL13176039 0.74 CCR2 (0.41) HCRTR1HCRTR2NPC1RAB9AALDH1A1
SCHEMBL2559047 0.73 NOTUM (0.49) GAACDC7CDK9EPHX2NPC1
SCHEMBL11277428 0.72 CSNK2A1 (0.44) GAAHCRTR1HCRTR2ALDH1A1SMN1; SMN2
SCHEMBL13175832 0.71 CCR2 (0.41) RAB9AALDH1A1HPGDCCR1CCR2
SCHEMBL27376861 0.70 CDC7 (0.44) GAAGFERCDC7CDK9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006097293-A2 COMBINATION OF A STEROID SULFATASE INHIBITOR AND AN ASCOMYCIN NOVARTIS AG (CH) 2006-09-21 WO disclosed